Videos

Omar Salamanca, MD, staff ophthalmologist, Orbis Flying Eye Hospital, discusses Orbis's tailored glaucoma training programs, which focus on hands-on surgical skills, early detection, telemedicine, and personalized follow-up care, helping underserved regions improve glaucoma management and blindness prevention.

In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s non-inferiority objectives, treatment schedule, patient outcomes like reduced treatment burden, and anatomical stability. Patient interest is high, particularly among those wanting fewer injections, though recruiting treatment-naive patients may be challenging. If results are favorable, potential FDA approval could occur within 3 to 4 years.

At the Tear Film and Ocular Surface meeting in Venice, Melissa Toyos shares findings on the mechanism of action of brimonidine tartrate.

New research sheds light on how the dry eye medication lifitegrast works beyond the ocular surface, targeting the underlying immune system to provide relief for patients.

Alfredo Sadun, MD, PhD, is the chief of Ophthalmology at the Doheny Eye Institute of UCLA. At this year's AAO meeting held in Chicago, Illinois, he stopped by the Eye Care Network booth to share insights from the symposium "Professional Longevity 2.0: Assessing the Ophthalmologist," which he presented during.

This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website.

In an interview with Ophthalmology Times, Ashley Brissette, MD, discusses her skincare brand, Daily Practice, created to address eye health concerns. Motivated by patient requests, she emphasizes the importance of ophthalmologist-tested products that ensure safety around the eyes. Brissette aims to integrate eye care into daily routines for all patients.

Glenn C. Yiu, MD, PhD, from the University of California David, shared insights from his presentation on suprachoroidal drug delivery in the real world at this year's AAO meeting held in Chicago, Illinois.

Vikas Chopra, MD, led a course on minimally invasive glaucoma surgery (MIGS) and its impact on glaucoma care. He explained that MIGS enables ophthalmologists to intervene earlier and more safely, which can lead to better outcomes for patients.

John Josephson, MD, from the Eye Specialists and Surgeons of Northern Virginia, shared insights on office-based surgeries and how it allows for the addition of new technologies and new procedures at this year's AAO meeting held in Chicago, Illinois.

Brian Francis, MD, from the Doheny Eye Institute and the UCLA Department of Ophthalmology, shared insights on MIGS techniques and the labs and didactic available while at this year's AAO meeting held in Chicago, Illinois.

Jonathan Brugger, MD, shared insights on the correlation of central retinal vein occlusions, or branch retinal vein occlusions, in young adults who consume numerous energy drinks.

This Week in Ophthalmology is a video series highlighting some of the top articles featured on the Ophthalmology Times website.

Weijie Violet Lin, MD, presented findings from her research, which revealed that post-cross-linking complications were low and highlighted key risk factors and the importance of early identification to enhance long-term patient outcomes.

At the American Academy of Ophthalmology (AAO) meeting in Chicago, Illinois, Brent Kramer, MD, he talked with the Eye Care Network about using the MKO Melt in lieu of IV anaesthesia ahead of ocular surgery.

John D. Sheppard, MD, MMSc, FACS, spoke with the Eye Care Network to provide some insight on post hoc analysis of the ESSENCE 1 trial dor dry eye disease.

During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr., MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.

Constance O. Okeke, MD, shared insights from on her presentation entitled, "Reduction in IOP after switching to latanoprostene bunod in glaucoma patients in real-world clinical practice," which was given at the American Academy of Ophthalmology held in Chicago, Illinois.

In a paper presented at the American Academy of Ophthalmology annual meeting in Chicago, Jonathan Tan, a third year medical student at the Icahn School of Medicine at Mount Sinai detailed the study on ophthalmic eye drop waste in clinics, revealing 72% medication loss due to outdated 28-day expiration guidelines, resulting in significant financial waste. The study advocates following FDA expiration dates.

Michael Singer, MD, shared insights from his experience using a preservative-free, chloroprocaine ophthalmic gel as anesthesia for intravitreal injections and the results of research on the effectiveness of gel versus traditional drops.

In a presentation at the American Academy of Ophthalmology’s annual meeting in Chicago, T.Y. Alvin Lu, MD, a retina specialist at Johns Hopkins Medicine, discussed the application of large language models (LLMs) in revenue cycle management (RCM).

Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.

At this year's American Academy of Ophthalmology (AAO) meeting, Jonathan Brugger, MD, spoke about the changing approach to epimacular membranes and the use of brilliant blue in the procedure.

Bonnie An Henderson, MD, highlights the importance of diverse learning methods and continuous education for clinicians in the Kelman Lecture.

Steven Dell, MD, shares insights from his first SMILE procedure case, detailing key surgical steps and the patient's postoperative experience.

Steven Dell, MD, provides an overview of the SMILE procedure, and shared what motivated him to adopt SMILE procedure in his practice

Kamran Riaz, MD, discussed with the Eye Care Network a study on mitomycin intravascular chemoembolization for treating corneal neovascularization. The procedure showed promise, with a 70% success rate at 3 to 6 months, though patient selection is crucial. Some required multiple treatments, but overall outcomes are promising.

George O. Waring, IV, MD, provides insights from an on-demand poster as part of the annual American Academy of Ophthalmology taking place in Chicago, Illinois. This poster was titled, "Two-Year Clinical Feasibility Trial Outcomes for a Dual-Optic IOL System for the Treatment of Presbyopia and Cataract."